43 results
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
23 Jun 23
2023 Annual General Meeting of Shareholders
4:15pm
. Sartani was the Vice-President of R&D and Licensing and Group coordinator of B&D of Recordati, a European specialty pharmaceutical company. Prior
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
28 Jun 21
Agreement with Vetbiolix for Development of Piclidenoson for Pets
7:08am
of prescription medicines, diagnostics, nutraceuticals and care products for pets, thanks to its qualified external R&D partners in Europe & the US. Vetbiolix
6-K
3mcb2fran 1gdjpjj
14 Jun 21
Current report (foreign)
4:30pm
6-K
EX-99.1
vsttplqglf90i dxfe6e
28 Oct 20
Report of Foreign Private Issuer
4:31pm
6-K
EX-99.1
wph8xmku1w1o im3f
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
gkvcojt
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
lx5iq3kei wvvq
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
jhl73j dxgkfl
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
k1srvo4rmfuu33d
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
6-K
EX-99.1
3yl1z0 covf
6 Nov 19
2019 Annual General Meeting of Shareholders
4:42pm
6-K
EX-99.1
1uka z8oub
10 Sep 19
Can-Fite Enters into Strategic Agreement with Univo Pharmaceuticals to Develop Cannabinoid-Based Pharmaceuticals and Assays
6:08am
20-F/A
qnrbgl
2 Apr 19
Annual report (foreign) (amended)
6:52am
424B3
zg1l7b9 d82q
22 Mar 19
Prospectus supplement
4:50pm
F-1/A
zuhazc9y
12 Mar 19
Registration statement (foreign) (amended)
4:20pm